Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Change in Cash (2020 - 2026)

Opus Genetics has reported Change in Cash over the past 12 years, most recently at $14.9 million for Q1 2026.

  • Quarterly Change in Cash rose 29.61% to $14.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $18.2 million through Mar 2026, up 438.37% year-over-year, with the annual reading at $14.8 million for FY2025, 173.19% up from the prior year.
  • Change in Cash was $14.9 million for Q1 2026 at Opus Genetics, up from $14.3 million in the prior quarter.
  • Over five years, Change in Cash peaked at $28.8 million in Q4 2022 and troughed at -$9.4 million in Q2 2025.
  • The 5-year median for Change in Cash is -$2.2 million (2022), against an average of $2.1 million.
  • Year-over-year, Change in Cash soared 1160.03% in 2022 and then tumbled 681.6% in 2024.
  • A 5-year view of Change in Cash shows it stood at $28.8 million in 2022, then crashed by 71.68% to $8.2 million in 2023, then tumbled by 177.43% to -$6.3 million in 2024, then skyrocketed by 326.21% to $14.3 million in 2025, then increased by 4.15% to $14.9 million in 2026.
  • Per Business Quant, the three most recent readings for IRD's Change in Cash are $14.9 million (Q1 2026), $14.3 million (Q4 2025), and -$1.6 million (Q3 2025).